Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $20.81 and traded as high as $27.73. Acadia Healthcare shares last traded at $27.69, with a volume of 2,456,146 shares trading hands.
Analysts Set New Price Targets
Several brokerages have recently commented on ACHC. Cantor Fitzgerald lifted their price target on shares of Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research report on Friday, May 1st. TD Cowen raised their price objective on shares of Acadia Healthcare from $24.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, April 28th. KeyCorp reaffirmed an “overweight” rating and set a $30.00 target price on shares of Acadia Healthcare in a report on Wednesday, May 27th. Guggenheim upped their target price on shares of Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Finally, Barclays increased their price target on Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, April 30th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $26.85.
Acadia Healthcare Price Performance
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.28 by $0.09. The business had revenue of $828.80 million for the quarter, compared to analysts’ expectations of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The firm’s revenue was up 7.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the company. EverSource Wealth Advisors LLC grew its holdings in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares in the last quarter. Wells Fargo & Company MN lifted its stake in Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after acquiring an additional 1,510 shares in the last quarter. Bayforest Capital Ltd acquired a new position in Acadia Healthcare during the 4th quarter worth approximately $52,000. GAMMA Investing LLC grew its stake in shares of Acadia Healthcare by 124.7% during the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after acquiring an additional 2,698 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its stake in shares of Acadia Healthcare by 4,264.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after acquiring an additional 5,203 shares in the last quarter.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.
Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.
Read More
- Five stocks we like better than Acadia Healthcare
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
